publication date: May. 15, 2015
20150515 - May. 15, 2015
ISSUE 19 – MAY 15, 2015PDF

Fisher Discusses Turnaround at Fox Chase

A year ago, Fox Chase Cancer Center lost money: $17 million.

In 2015, the losses have stopped and an $8 million operating profit is projected. Fox Chase is part of the Temple University Health System, which is rebuilding its cancer services around the venerable center.

“We’re in an interesting time at Fox Chase—because as I look ahead to the future of health care and accountable care coming, I think it’s unlikely if many, if any, of the freestanding cancer centers will be able to stand by themselves in that kind of arrangement,” Fisher said to The Cancer Letter. “So right now, we’re a fascinating model that’s going to be looked at by our colleagues to see how it works.”

21st Century Cures Passes House Subcommittee

The 21st Century Cures bill—a bipartisan initiative aimed at streamlining development of drugs and medical devices—received unanimous approval May 14 from the Health Subcommittee of the House Energy and Commerce Committee.

Congressional leaders expect a full committee markup next week, and a floor vote in June.

Guest Editorial

AACR: 21st Century Cures a “Model for an Open and Honest Conversation”

By José Baselga and William S. Dalton

Almost one year ago (on April 30, 2014), House Energy and Commerce Committee Chairman Fred Upton (R-Mich.), along with Oversight and Investigations Subcommittee Ranking Member Diana DeGette (D-Colo.) announced the launch of 21st Century Cures, an initiative aimed at accelerating the pace of cures and medical breakthroughs in the United States by ensuring that our laws are keeping pace with innovation.


    ASCO Annual Meeting 2015

    Highlights of Selected Studies

    The American Society of Clinical Oncology announced results from four major studies May 13, which will be presented at the society’s 51st Annual Meeting, May 29 to June 2, in Chicago.


    Study: Discrepancy in Definition of “Value” in Cancer Care

    The “value” of cancer care may be interpreted differently among health care stakeholders, according to a study by the Cancer Support Community, an international nonprofit.

    The study, “Defining Value in Oncology: Perspectives from Patients with Metastatic Breast Cancer,” asked 769 patients to define value, based on their cancer experience.


    Report: Global Cancer Spending Reaches $100 Billion Mark

    Global spending on oncology drugs in 2014 reached $100 billion, up 10.3 percent over 2013 and up from $75 billion in 2010, according to the 2015 Global Oncology Trend Report, published by the IMS Institute for Healthcare Informatics. The annual compound growth rate increased to 6.5 percent over the past five years.

    The study, “Developments in Cancer Treatments, Market Dynamics, Patient Access and Value,” found that the U.S. and the five largest European nations continue to spend the most in oncology, making up two-thirds of the total international market.

    In Brief

    • Sotomayor named first director of GW Cancer Center

    • Lisa Kachnic named chair of department of radiation oncology at Vanderbilt-Ingram Cancer Center

    • MD Anderson makes several changes in executive leadership

    • Michael Simon wins award from Blue Cross Blue Shield of Michigan Foundation 
    • Eric Liu to join Rocky Mountain Cancer Centers
    • Maryland Proton Therapy Center completes funding
    Drugs and Targets

    • FDA grants fast track designation to evofosfamide

    • Eli Lilly and Company and BioNTech AG launch research collaboration

    • FDA approves cobas KRAS mutation test

    Copyright (c) 2020 The Cancer Letter Inc.